Medical Marijuana: Canopy Growth In Australia

Ontario, Canada-based Canopy Growth Corp. said it has signed a supply agreement with AusCann Group Holdings Ltd. to be its exclusive supplier of medical cannabis for the Australian market.

Canopy will transfer a range of medicines for research and commercialization in Australia. The deal will also allow Canopy to pursue other Australian opportunities.

"This agreement is a positive step in enabling Australian patients to have access to high quality cannabinoid medications," said Elaine Darby, Managing Director, AusCann. "I'm excited to move forward with this partnership, and continue to utilize the production scale of existing partners to accelerate our own sales function and market presence."

This agreement follows a recent deal the company signed with Alcaliber S.A. to provide certain marijuana strains and seeds.